Glycolic Is the Fastest Acid. That's Its Design Flaw.
The smallest AHA gets deepest and shows results soonest — which is precisely why routines built around it overshoot, and why the people who do best with it use it least.
Combines three-acid complex (glycolic + lactic + gluconolactone PHA) with shea butter, argan oil, prickly pear extract, and substantive multi-humectant architecture in a single clinical lip rejuvenation treatment. Most lip exfoliating products are basic sugar scrubs or single-acid serums; this delivers multi-acid resurfacing with substantive lipid-and-hydration support.
An ambitious clinical lip exfoliating treatment from Obagi's 2026 Lip Therapy protocol launch — three-acid complex (glycolic + lactic + gluconolactone PHA) with substantive lipid-and-emollient phase and multi-humectant architecture in a single fragrance-free formula. The clinical formulation depth distinguishes this from basic lip scrubs, and the pairing with the matching Lip Therapy SPF 30 supports comprehensive lip care. The $55 price and limited consumer availability through physician channel narrow the demographic, but for the target users this delivers genuine multi-mechanism lip rejuvenation.
Launched February 3, 2026 as part of Obagi's new Lip Therapy protocol — only months of post-launch data accumulating at the time of writing. Scoring blends formulation analysis with the established Obagi brand clinical credibility.
The case for it
What would change this: A declared concentration would move this to a firmer reading of the dose.
Same rule for everyone. “Good choice” is the verdict on 9,564 of 45,024 concern verdicts across the catalog; rule R5 decided 9,072 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
The case for it
What would change this: A declared concentration would move this to a firmer reading of the dose.
Same rule for everyone. “Good choice” is the verdict on 9,564 of 45,024 concern verdicts across the catalog; rule R5 decided 9,072 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
The case for it
Cautions: a photosensitising active — use sun protection.
What would change this: A declared concentration would move this to a firmer reading of the dose.
Same rule for everyone. “Promising” is the verdict on 7,858 of 45,024 concern verdicts across the catalog; rule R9p decided 7,858 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
The case for it
What would change this: A declared concentration would move this to a firmer reading of the dose.
Same rule for everyone. “Good choice” is the verdict on 9,564 of 45,024 concern verdicts across the catalog; rule R5 decided 9,072 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
As a lip balmNot judged: what a lip balm is for — seals and protects, sun protection where it matters — cannot yet be measured from the ingredient list (only no sting-and-repeat ingredients, low allergen load can).
Where our review and the verdict differ. The review below was written on the formulation and the published trials; the verdicts above apply the stricter standing test in our methodology — an active earns a recommendation only with guideline or regulatory standing for the concern. Where the two disagree, the verdict is DermApproved’s position.
A verdict is DermApproved’s assessment of how well a product’s ingredients fit a concern — never a claim about what the product treats. Evidence dots and collected reviews sit beside it and are never blended in. Rules 0.5.1 · evidence table ev-2026.09-r228 · how we decide
Lips have always been the part of the face that clinical skincare forgot. The category splits neatly into two underwhelming halves: basic balms that hydrate and protect, and basic scrubs that abrade with sugar or salt particles. Neither touches the broader territory of lip rejuvenation, the cellular turnover, structural lipid replenishment, and fine-line management that facial chemistry has poured decades of investment into. Obagi Medical, a legacy clinical brand, decided to fill that gap, launching its first dedicated Lip Therapy protocol in early 2026, and the AHA + PHA Smoothing Micro-Peel is its resurfacing nighttime step, designed to be paired with a Soothe & Protect SPF 30 day treatment so the lips finally get the same morning-and-night logic the rest of a serious routine already follows.
The formula's defining move is its three-acid complex. Glycolic acid, a small and penetrating AHA, drives surface cellular turnover by loosening the bonds between dead cells. Lactic acid, a gentler AHA that doubles as a humectant, adds further exfoliation while holding water at the surface. Gluconolactone, a polyhydroxy acid or PHA, supplies the gentlest exfoliating mechanism of the three and brings hydrating properties of its own. The point of layering three acids rather than leaning on one is that each works through a slightly different pathway, and the combined effect smooths from several angles at once without the sharp irritation a single high-strength lip acid can cause, which is especially important given that lip skin is thinner and more vulnerable than facial skin. These are well-established actives used at concentrations chosen for delicate tissue rather than the more aggressive levels you would find in a facial peel, which is the whole reason this reads as a treatment rather than a chemical burn waiting to happen.
What distinguishes this from a stripping scrub is everything built around the acids. A substantial multi-humectant architecture sits high in the formula, diglycerin, propanediol, glycerin, and pentylene glycol layered together, and it keeps the exfoliation from dehydrating the lips while it works. Sodium hyaluronate adds further surface humectant support. Then comes a genuine lipid-and-emollient phase: shea butter for barrier-replenishing cushion, argan oil for vitamin E and fatty-acid support, and opuntia prickly pear fruit extract contributing polysaccharide humectant work characteristic of premium lip formulations. That lipid component matters more than it might seem, because rough, aging lips are not only a cellular-turnover problem but a lipid-deficiency one, and addressing both at the same time is the entire argument for the product over a plain acid serum.
The lip-specific framing matters here, because so many people treat their lips as an afterthought sealed with whatever balm is nearest, and the result is texture and fine lines that the rest of a careful routine never touches. A treatment built for that exact tissue, at concentrations scaled to it, is a genuinely sensible idea even before you reach the formula. In use it behaves like a treatment rather than a scrub: a gel-cream that spreads smoothly and absorbs in about a minute to a comfortable, hydrated finish, and it is truly fragrance-free in keeping with Obagi's clinical formulation philosophy. The acids may produce a mild tingle on the first few uses that settles within minutes, and lips feel noticeably smoother after a single application, with cumulative texture and fine-line improvement developing over four to six weeks of consistent use two or three times a week.
The tradeoffs are specific and worth naming plainly. At 55 dollars for 15ml, this is an expensive lip product, roughly 3.67 dollars per milliliter, and the review volume so far is under a hundred, which means long-term user data is genuinely thin for this recent 2026 launch and the data confidence here is honestly rated low. Obagi's physician-distribution model limits availability outside dermatology and aesthetic-medicine channels, so it is not a grab-it-anywhere purchase. The shea butter and C12-13 alkyl lactate are comedogenic, which can be a consideration for fungal-acne-prone skin around the mouth and chin. And the acid combination, gentle as it is engineered to be, may still be too much for very sensitive lip biology, so cautious users should start at once a week and build up. One genuine plus worth emphasizing: with no salicylic acid in the formula, it is pregnancy-safe, which broadens who can reach for it.
Where it lands: for the clear, narrow brief of wanting a clinical-tier lip exfoliating treatment that goes beyond sugar scrubs and single-acid serums, this is among the more thoughtfully designed options currently available, combining multi-acid resurfacing with real lipid-and-hydration support rather than stripping the lips and leaving them to fend for themselves. The Obagi clinical credibility and the matching SPF 30 daytime partner make it a coherent protocol rather than a one-off purchase. For users already inside the Obagi physician ecosystem who want comprehensive lip care alongside a facial program, the chemistry delivers honestly on its positioning; for everyone else, the price and the limited access are the two questions to settle before committing, because the formula itself is not where the hesitation should be. It is also worth being honest that lip texture and fine lines respond slowly and partially to any topical, so even a well-built treatment like this is a steady, modest improver rather than a dramatic one, and the buyer who expects plumper, glassier lips overnight will undersell what it does well while overestimating what any lip peel can do.
The hero actives that drive this product's performance.
| Ingredient | Function | Evidence |
|---|---|---|
| Three-Acid Complex (Glycolic Acid + Lactic Acid + Gluconolactone PHA) | Triple-acid exfoliating combination — glycolic acid (AHA) for surface cellular turnover, lactic acid (gentler AHA) for additional exfoliation with humectant properties, gluconolactone (PHA) for the gentlest exfoliating mechanism. The combination delivers measurable lip surface smoothing without the aggressive irritation that single-acid lip products can cause. The three-acid approach addresses lip texture from multiple complementary mechanisms. | Established mechanism for Rough Texture · established mechanism |
| Sodium Hyaluronate | Mid-INCI HA provides humectant work that supports lip hydration during the exfoliation process. The combination of exfoliation with hydration delivery is what distinguishes this from basic lip scrubs that strip without replenishing. | Established mechanism for Dehydration · established mechanism |
| Shea Butter + Argan Oil + Opuntia (Prickly Pear) Fruit Extract | Lipid-and-emollient phase delivering substantive nourishment alongside the acid work. Shea butter provides barrier replenishment. Argan oil delivers vitamin E and fatty acid support. Opuntia fruit extract adds polysaccharide humectant work characteristic of premium lip formulations. The combination addresses the lipid-deficiency component of lip texture concerns. | Established mechanism for Dryness · established mechanism |
| Multi-Humectant Pool (Diglycerin + Propanediol + Glycerin + Pentylene Glycol) | Substantial humectant architecture in the top INCI positions delivers the hydration support that allows the acid work to operate on lip skin without dehydration. Glycerin and the related polyols provide layered humectant work appropriate for the delicate lip skin biology. | Established mechanism for Dryness · established mechanism |
Ingredient standings describe the active at treatment-level doses and vehicles; this product's own condition grades weigh its actual formula.
Aqua/Water/Eau, Diglycerin, Propanediol, Glycerin, Pentylene Glycol, Acrylamide/Sodium Acryloyldimethyltaurate Copolymer, Butyrospermum Parkii (Shea) Butter, Sodium Hyaluronate, Glycolic Acid, Lactic Acid, Gluconolactone, Argania Spinosa Kernel Oil, Opuntia Tuna Fruit Extract, Caesalpinia Spinosa Gum, Hydroxyacetophenone, Sorbitan Caprylate, Sodium Hydroxide, Polyglyceryl-10 Laurate, C15-19 Alkane, 1,2-Hexanediol, C12-13 Alkyl Lactate, Sorbitan Oleate, Polyglycerin-10.
treatment
PM
Apply to clean lips at night, 2-3 times weekly for ongoing maintenance. The micro-peel format delivers gentler exfoliation than physical lip scrubs and can be used more frequently. Follow with the matching Lip Therapy SPF 30 Treatment in the morning or with a lip balm at night. Avoid using around the mouth where the acid concentration may be too intense for facial skin.
Immediate visible lip smoothness after the first use as the acid complex addresses surface texture. The cumulative lip texture and fine line improvements develop over 4-6 weeks of consistent 2-3x weekly use.
The formulation case combines three validated exfoliating acids with substantive supporting cast. Glycolic acid (AHA) has extensive research support for cellular turnover through stratum corneum bond loosening. Lactic acid provides similar AHA mechanism with humectant properties and gentler profile. Gluconolactone (PHA) delivers the gentlest exfoliating mechanism with hydrating properties. The combination addresses cellular turnover from multiple complementary mechanisms at concentrations appropriate for delicate lip skin.
Hyaluronic acid provides documented surface humectant work. Shea butter and argan oil deliver well-characterized barrier-replenishing emollient effects. Opuntia (prickly pear) fruit extract has emerging research support for polysaccharide humectant work.
The overall formulation design represents a deliberate clinical-tier multi-mechanism approach to lip rejuvenation through complementary exfoliating and hydration-supporting chemistry.
Within Western dermatological practice, the Obagi Lip Therapy protocol launch has been generally well-received as the brand's clinical entry into the underserved lip care category. The Micro-Peel specifically is recommended for patients wanting lip rejuvenation alongside facial skincare programs. The Obagi physician-distribution model integrates this lip protocol with broader dermatology practice.
Apply to clean lips at night, 2-3 times weekly. Gently massage across lip surface for 30 seconds, then leave on as a treatment. Follow with lip balm to support hydration overnight. In the morning, follow up with the matching Obagi Lip Therapy Soothe & Protect Lip Treatment SPF 30 for daytime protection. Avoid using around the mouth (skin around lips) as the acid concentration may be too aggressive for facial skin.
$55 USD for 15ml puts the per-mL cost at approximately $3.67 — substantial for the lip product category. The product lasts approximately three to four months at 2-3 weekly use, putting the per-application cost around $0.55-0.70. For users committed to clinical lip care with the Obagi physician-distribution model, the math works. For users wanting basic lip exfoliation, drugstore lip scrubs at $5-15 serve different goals.
Users committed to clinical lip rejuvenation with the Obagi physician-distribution model. Users wanting comprehensive lip care that addresses cellular turnover, lipid replenishment, and fine lines. Obagi Medical patients integrating lip care with facial skincare programs.
Users wanting basic lip exfoliation at lower price should look at drugstore lip scrubs. Users with very sensitive lip biology may find the acid concentration too aggressive. Fungal-acne-prone users with around-mouth bumps should avoid given the comedogenic content. Users for whom $55 represents inappropriate lip product investment should choose sustainable price-tier alternatives.
Ready to try Obagi Lip Therapy AHA + PHA Smoothing Micro-Peel?
Buy at Amazon ♥Gel-cream that spreads smoothly on lips and absorbs in about a minute, leaving a comfortable hydrated finish.
Truly fragrance-free per Obagi clinical formulation philosophy.
15ml tube in Obagi Lip Therapy line's clinical packaging.
First application feels comfortable on lips with the gel-cream texture absorbing quickly. The acids may produce mild tingling on initial uses that resolves within minutes. Lips feel notably smoother after the first use with continued improvement over weeks.
Approximately three to four months at 2-3 times weekly use.
All Year
Obagi Medical launched its first dedicated Lip Therapy protocol on February 3, 2026, with the AHA + PHA Smoothing Micro-Peel as the resurfacing nighttime step paired with the SPF 30 Soothe & Protect daytime step. The two-product protocol reflects Obagi's clinical positioning applied to the underserved lip care category.
Part of Obagi Medical's 2026 Lip Therapy protocol launch — the brand's first dedicated lip rejuvenation product line, applying the clinical Obagi formulation philosophy to the underserved lip care category.
Lip skin is too delicate for acid treatments.
Lip skin requires more gentle formulation than facial skin acid treatments, but well-formulated multi-acid combinations like this Obagi product can deliver effective lip exfoliation without barrier disruption. The substantive humectant and emollient supporting cast addresses the lip-specific hydration needs.
Sugar lip scrubs are gentler than chemical exfoliants for lips.
Sugar scrubs deliver only mechanical exfoliation that can damage lip skin barrier through abrasive action. Properly formulated chemical exfoliants like this Obagi micro-peel work through targeted cellular turnover mechanisms without abrasion. Modern chemistry is generally gentler than physical scrubbing for lip applications.
2-3 times weekly for ongoing maintenance. The micro-peel format is gentler than physical lip scrubs and can be used more frequently than intensive lip peels. Daily use is appropriate for established users with resilient lip skin who tolerate the acid combination.
Yes — the formula contains AHA and PHA but no salicylic acid or other restricted pregnancy actives. The glycolic acid at the low concentration in a localized lip application is considered acceptable during pregnancy. Consult your dermatologist for personalized guidance.
Yes — the two-product protocol is the recommended Obagi Lip Therapy routine. Use the Micro-Peel at night for resurfacing and the SPF 30 in the morning for protection. The pairing provides comprehensive lip care addressing both rejuvenation and prevention.
Yes, gradually. The cellular turnover from the three-acid complex addresses surface texture and fine line appearance over 4-6 weeks of consistent use. For deeper lip lines, in-office treatments (laser, fillers) deliver stronger results that topical products cannot match.
Depends on user priorities. For users committed to clinical-tier lip care and the Obagi physician-distribution model, the math works. For users wanting basic lip exfoliation, drugstore lip scrubs at $5-15 serve different goals. The Obagi premium reflects the multi-acid formulation depth and the clinical brand credibility.
Recurring themes our editors read across retailer reviews of this product — summaries in our words, not quotations, and not a substitute for your own patch test.
Early adopters consistently note immediate lip smoothness after use
Multi-acid approach gentler than single-acid lip products
Substantive lipid replenishment alongside exfoliation
Too few reviews to establish patterns, but the $55 price is the most common concern
Limited consumer availability outside physician channel
Acid concentration may be too aggressive for very sensitive lip biology